Research project

Dr Cragg: BH3-only proteins and micorenvironmental niches in the development and treatment resistance of CLL

Staff

Lead researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Research outputs